| Methods of model calibration: observations from a mathematical model of cervical cancer DCA Taylor, V Pawar, D Kruzikas, KE Gilmore, A Pandya, R Iskandar, ... Pharmacoeconomics 28, 995-1000, 2010 | 56* | 2010 |
| A theoretical foundation for state-transition cohort models in health decision analysis R Iskandar PloS one 13 (12), e0205543, 2018 | 17 | 2018 |
| Regulatory and HTA early dialogues in medical devices CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ... Health Policy 125 (10), 1322-1329, 2021 | 15 | 2021 |
| The ONCOTYROL prostate cancer outcome and policy model: effect of prevalence assumptions on the benefit-harm balance of screening N Mühlberger, C Kurzthaler, R Iskandar, MD Krahn, KE Bremner, ... Medical Decision Making 35 (6), 758-772, 2015 | 12 | 2015 |
| Microsimulation model calibration with approximate bayesian computation in r: A tutorial P Shewmaker, SA Chrysanthopoulou, R Iskandar, D Lake, E Jutkowitz Medical Decision Making 42 (5), 557-570, 2022 | 8 | 2022 |
| Active learning for efficiently training emulators of computationally expensive mathematical models AG Ellis, R Iskandar, CH Schmid, JB Wong, TA Trikalinos Statistics in Medicine 39 (25), 3521-3548, 2020 | 8 | 2020 |
| Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices DCA Taylor, V Pawar, D Kruzikas, KE Gilmore, A Pandya, R Iskandar, ... Value in Health 14 (5), 700-704, 2011 | 8 | 2011 |
| Age-specific rates of onset of cannabis use in Mexico M López-Méndez, A Ospina-Escobar, R Iskandar, F Alarid-Escudero Addictive behaviors 122, 107038, 2021 | 4 | 2021 |
| An approach to quantify parameter uncertainty in early assessment of novel health technologies R Iskandar, C Federici, C Berns, CR Blankart Health economics 31, 116-134, 2022 | 3 | 2022 |
| Probability bound analysis: A novel approach for quantifying parameter uncertainty in decision-analytic modeling and cost-effectiveness analysis R Iskandar Statistics in Medicine, 2021 | 3 | 2021 |
| Mathematical models for evaluating effectiveness and cost-effectiveness of cervical cancer control policies in populations including women living with human immunodeficiency … R Iskandar, K Taghavi, N Low, WM Bramer, M Egger, E Rohner Value in health regional issues 32, 39-46, 2022 | 1 | 2022 |
| Adding noise to Markov cohort state‐transition model in decision modeling and cost‐effectiveness analysis R Iskandar Statistics in medicine 39 (10), 1529-1540, 2020 | 1 | 2020 |
| A Theoretical Model Of Breast Tumor Metastases In The Context Of Tumor Dormancy R Iskandar | 1 | 2016 |
| The Oncotyrol Prostate Cancer Outcome and Policy Model-How latent prevalence affects the benefit-harm balance of screening N Mühlberger, EAM Heijnsdijk, C Kurzthaler, R Iskandar, MD Krahn, ... Value in Health 17 (7), A559, 2014 | 1 | 2014 |
| Economic evaluation of DVd versus VAd in the treatment of multiple myeloma: Results from a phase III multicenter randomized clinical trial RM Rifkin, M Hussein, R Iskandar, A O’Sullivan, D Thompson, J Forlenza, ... Journal of Clinical Oncology 24 (18_suppl), 6050-6050, 2006 | 1 | 2006 |
| RS2 COST-EFFECTIVENESS OFTELITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA LJ McGarry, R Iskandar, B Seal, C Asche, D Thompson, MC Weinstein Value in Health 3 (9), A6, 2006 | 1 | 2006 |
| Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe N Garnier, J Berghout, A Zygmunt, D Singh, KA Huang, W Kantz, ... Plos one 18 (11), e0293503, 2023 | | 2023 |
| Individual and Dyadic Health-Related Quality of Life of People Living with Dementia and their Caregivers M Lopez-Mendez, R Iskandar, E Jutkowitz Applied Research in Quality of Life 18 (4), 1673-1692, 2023 | | 2023 |
| The impact of perioperative diagnostic tools on clinical outcomes and cost-effectiveness in parathyroid surgery: a health economic evaluation D Batora, R Iskandar, J Gertsch, RM Kaderli medRxiv, 2023.12. 04.23299113, 2023 | | 2023 |
| Markov cohort state-transition model: A multinomial distribution representation R Iskandar, C Berns Medical Decision Making 43 (1), 139-142, 2023 | | 2023 |
